Basic Infertility Work Up and Initial Treatment
Basic Infertility Work Up and Initial Treatment
Basic Infertility Work Up and Initial Treatment
• FECUNDITY- ability to
achieve live birth with
one menstrual cycle.
MAJOR CHANGES IN
INFERTILITY PRACTICE:
• 1. Introduction of IVF and other ART
procedures.
• 2. Increased public awareness.
• 3. Increased proportion of women over the
age of 35
– 1/5 of U.S. women have first child after 35 y/o.
2 CATEGORIES:
• 1. Low fecundability- hypo fertile,
eventually able to conceive.
• E.g.. Oligospermia; mild endometriosis
• 2. Sterile- never able to conceive.
• Male: azospermia
• Female: complete occlusion of
oviducts.
2 FACTORS REDUCING
CONCEPTION:
• 1. Incidence of infertility increased in
increasing age of female.
• 3. OVARIAN FAILURE:
– ↑FSH; N Estradiol; ↓ Inhibin
• Treatment:
– Thyroid hormone replacement
– Bromocriptine
LUTEAL DEFECIENCY:
• serum progesterone level below 10ng/ml
in luteal phase of several cycles.
– deficit in progesterone production.
– Never established to cause infertility.
– Diagnosed Histologically- the normal
secretory endometrial development must lag
3 days or more , behind the expected pattern
of the time of the cycle, consistent finding in 2
cycles.
IMMUNOLOGIC CAUSE OF
INFERTILITY:
• In women:
– sperm agglutinating antibody
• 3. Additional tests:
• - Serum FSH and prolactin in ovulatory women.
• - Luteal phase endometrial biopsy.
• - Measure of anti-sperm antibody of both male and
the female partner.
• - Bacteriologic cultures of cervical mucus and semen.
• - Hamster egg penetration test.
MANAGEMENT:
• MALE:
– General measures
– adequate sleep, diet and exercise
– Moderation in use of alcohol, and tobacco
– Relief of emotional tension.
– avoidance of regimented coitus, as long as
exposures average 2-3 times a week.
– weight reduction in obesity.
– Treatment of chronic illness or metabolic
disorder.
– avoidance of prolonged heat to scrotum.
– Urologic consultations in those with
oligospermia or azospermia.
– Varicocoele should be excluded.
– Chromosomal studies in those with
abnormality in external genitalia.
Treatment of Oligospermia:
• Triiodothyronine
• -Clomiphene Citrate
• -Human Menopausal Gonadotropin
• -HCG
• - oral androgens
• -Cortisone therapy
Treatment of FEMALE:
• OVARIAN FACTOR:
• Ovulation Defects
– nutritional deficiencies
– metabolic disorders
– chronic illness
– neurogenic disorders
– psychogenic disorders
– specific ovarian disorders
• e.g.. Ovarian tumors, PCOS, ovarian dysgenesis
• Endometriosis
– OCPs
– Danazol
– GnRH agonists
• Peri-ovarian Adhesions
– a. lysis of adhesions
– b. suspension of uterus
– c. corticosteroids
• Inadequate Luteal Phase
– General constitutional measures should not be
over-looked.
– Clomiphene Citrate = 50 mg/day for 5 days at Day 5
of cycle.
– Low dosage Estrogen from day 5 to midcycle.
– Progesterone deficiencies- give progesterone
– HCG to induce endogenous progesterone secretion.
TUBAL FACTOR: